The formulation described has not been reviewed by the FDA for safety or efficacy
Advances in enteric coating, nanoparticle encapsulation, and peptide stapling are opening pathways to oral bioavailability a potential game-changer for therapeutic applications
The seller makes no representations or warranties , express or implied, regarding fitness for any particular purpose
98%+ HIGHLY PURIFIED AND BIOAVAILABLE - Our glutathione pills are derived via a fermentation process to ensure a highly stable formula
A multicenter phase I/II trial showed significant efficacy of oral pan-HDAC inhibitor Abexinostat (45 mg/m twice daily, 7 days on/intermittent dosing) in relapsed follicular lymphoma, with a 64.3% ORR and 20.5-month median PFS
Because the peptide is not FDA-approved, it exists in a regulatory gray area